FDAnews
www.fdanews.com/articles/96268-roche-8217-s-new-ceo-schwan-hopes-alnylam-will-be-8216-second-genentech-8217

Roche’s New CEO Schwan Hopes Alnylam Will Be ‘Second Genentech’

July 24, 2007

Roche Holdings AG’s new chief-executive-in-waiting, Severin Schwan hopes that new partner Alnylam Pharmaceuticals Inc will be Roche’s ‘second Genentech’ in the US, he said in an interview with Swiss weekly SonntagsZeitung.
CNN Money